Charisse Winecki, head of the U.S. general market at Genomma Lab, sees an opportunity for Bufferin to gain market share among consumers. She talked about the reintroduction of the brand into the ...

This article first appeared on GuruFocus. Genomma Lab Internacional SAB de CV (MEX:LABB) is set to release its Q3 2025 earnings on Oct 22, 2025. The consensus estimate for Q3 2025 revenue is $4.92 ...

Genomma Lab Internacional SAB de CV (GNMLF) recently announced a dividend of $0.2 per share, payable on 2023-12-27, with the ex-dividend date set for 2023-12-22. As investors look forward to this ...

MEXICO CITY, June 12, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of Mexico's leading pharmaceutical and personal care companies ...

(2) EBITDA defined as operating income before depreciation and amortization (3) Proforma Net Income = Net Income – Foreign Exchange Result – Inflationary Result from Monetary Position Like-for-like ...

Genomma Lab Internacional SAB de CV Class B ((MX:LABB)) has held its Q3 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful ...

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a ...

("Genomma Lab" or "the Company"), one of the leading Pharmaceutical and personal care product companies in Mexico with an increasing international presence, today announced four independent bolt-on ...

Agreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma’s Strategic Marketing and Distribution Footprint “We’re excited to partner with Genomma, as this collaboration ...

HOUSTON--(BUSINESS WIRE)--As consumers continue to adapt their behaviors due to the COVID-19 pandemic, offering quality and known products that can help them with their day-to-day life in the “new ...

Net sales: +5.0% increase reflecting strong Suerox sales growth across markets, primarily offset by a weaker-than-expected flu season and related market share loss of Genomma cough & cold brands in ...

Agreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma's Strategic Marketing and Distribution Footprint Genomma Lab Internacional, S.A.B. de C.V. is one of the ...